Brii Bio is a biotechnology company that is engaged in the research and development of new medicines for unmet diseases. Read more

6 Followers on Owler
6 Followers on Owler
6 Followers on Owler
6 Followers on Owler

Brii Bio is a biotechnology company that is engaged in the research and development of new medicines for unmet diseases. Read more

Zhi Hong's photo - President & CEO of Brii Bio

President & CEO

Zhi Hong

CEO Approval Rating

89/100

Founded:

2018

Status:

PrivateIndependent Company

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Sino Biological is perceived as one of Brii Bio's biggest rivals. Sino Biological was founded in 2007 in Beijing, Beijing Municipality. Sino Biological is in the Biotechnology field. Sino Biological generates $27.5M more revenue than Brii Bio.

Innovent is Brii Bio's #2 rival. Innovent is a Public company that was founded in 2011 in Suzhou, Jiangsu Province. Innovent competes in the Pharmaceuticals field. Compared to Brii Bio, Innovent has 1,963 more employees.

BeiGene is one of Brii Bio's top competitors. BeiGene's headquarters is in Beijing, Beijing Municipality, and was founded in 2010. Like Brii Bio, BeiGene also operates in the Biotechnology industry. BeiGene generates 10,356% of Brii Bio's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 19 a good estimate for Brii Bio's Employee count?

Acquisitions

No recent acquisitions found related to Brii Bio

Brii Bio Funding History

$260M

Since Brii Bio was founded in 2018, it has participated in 1 round of funding. In total Brii Bio has raised $260.0M. Brii Bio's funding round was on May 2018 for a total of $260.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
May 2018
$260M

ARCH Venture Partners

Since Brii Bio was founded in 2018, it has participated in 1 round of funding. In total Brii Bio has raised $260.0M. Brii Bio's funding round was on May 2018 for a total of $260.0M

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

AN2 Therapeutics is a biopharmaceutical company that develops drugs for patients suffering from infectious diseases.
$12M
Nov 20, 2019
Series A
-

Brii Bio News

April 1, 2020Pharmaceutical Business Review

Tsinghua and partners to develop neutralising antibodies against COVID-19

The parties, which have signed a partnership and license agreement, have agreed to discover, develop,... See more »
April 1, 2020FierceBiotechIT

Brii, Chinese partners eye Q3 start for COVID-19 antibody trial

Brii Biosciences has teamed up with a Chinese hospital and university to develop antibodies against C... See more »
March 12, 2020BioPortfolio

Brii Biosciences to fund coronavirus research at Columbia University

Visit our Covid19 microsite for the latest coronavirus news analysis and updates Follow the latest up... See more »
December 5, 2019Biospectrum Asia

Brii Biosciences expands focus to neurosciences

Brii Biosciences Expands Therapeutic Focus to Include Neurosciences... See more »
December 3, 2019BioPortfolio

Brii Biosciences Expands Therapeutic Focus to Include Neurosciences with Addition of John Kraus M.D. Ph.D.

Dr. Kraus to lead newlycreated Neurosciences Therapy Area Zhijian Chen Ph.D. named Strategic Scientif... See more »
November 22, 2019BioPortfolio

Brii Bio Inlicenses Seven AntiInfectives from Three Companies

Brii Biosciences a ShanghaiUS antiinfectives company announced partnerships that add up to seven new ... See more »
November 21, 2019FinSMEs

AN2 Therapeutics Raises $12M in Series A Funding

AN2 Therapeutics, Inc., a Menlo Park,...... See more »

Brii Bio Press Releases

Social Media

Headquarters

No.686, Jiujiang Road 7th Floor, Room 112

Shanghai, Shanghai Municipality200001

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Brii Bio is a biotechnology company that is engaged in the research and development of new medicines for unmet diseases. Brii Bio was founded in 2018. Brii Bio's headquarters is located in Shanghai, Shanghai Municipality, CN 200001. It has raised 260....

CEO

Brii Bio's President & CEO, Zhi Hong, currently has an approval rating of 89%. Brii Bio's primary competitors are Sino Biological, Innovent & BeiGene.

Website

briibio.com

Frequently Asked Questions about Brii Bio

  1. When was Brii Bio founded?

    Brii Bio was founded in 2018
  2. Who is Brii Bio's CEO?

    Brii Bio's CEO is Zhi Hong
  3. How much revenue does Brii Bio generate?

    Brii Bio generates $2.5M in revenue
  4. How much funding does Brii Bio have?

    Brii Bio has historically raised $260M in funding
  5. Where is Brii Bio's headquarters?

    Brii Bio's headquarters is in Shanghai Shanghai Municipality, CN
  1. How many employees does Brii Bio have?

    Brii Bio has 19 employees
  2. What sector does Brii Bio operate in?

    Brii Bio is in Biotechnology, Pharmaceuticals
  3. Who are Brii Bio's competitors?

    Brii Bio's top competitors are Sino Biological, Innovent, BeiGene
  4. Who has Brii Bio invested in?

    Brii Bio's has invested in companies such as AN2 Therapeutics